High–dose intravenous immunoglobulin therapy in chronic progressive lumbosacral plexopathy

Research output: Contribution to journalArticle

45 Scopus citations

Abstract

Previous reports of primary lumbosacral plexopathy (LSP) have stressed the benign nature of the syndrome. No effective treatment is known for the occasional patients who do not recover or who have relapses. We report two patients presenting with a progressive form of idiopathic LSP. Both patients showed remarkable improvement on high-dose intravenous immunoglobulin therapy. We suggest that these patients represent a treatable subgroup of LSP.

Original languageEnglish (US)
Pages (from-to)248-250
Number of pages3
JournalNeurology
Volume44
Issue number2
DOIs
StatePublished - Feb 1994

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'High–dose intravenous immunoglobulin therapy in chronic progressive lumbosacral plexopathy'. Together they form a unique fingerprint.

  • Cite this